HomeCHHMF • OTCMKTS
add
ChemoMetec A/S
Market news
Financials
Income Statement
Revenue
Net income
| (DKK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 125.74M | 25.86% |
Operating expense | 52.26M | 10.05% |
Net income | 51.68M | 46.48% |
Net profit margin | 41.10 | 16.40% |
Earnings per share | — | — |
EBITDA | 65.49M | 45.88% |
Effective tax rate | 22.20% | — |
Balance Sheet
Total assets
Total liabilities
| (DKK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 264.74M | 14.04% |
Total assets | 730.22M | 23.03% |
Total liabilities | 132.24M | 39.52% |
Total equity | 597.98M | — |
Shares outstanding | 17.40M | — |
Price to book | — | — |
Return on assets | 21.57% | — |
Return on capital | 26.00% | — |
Cash Flow
Net change in cash
| (DKK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 51.68M | 46.48% |
Cash from operations | 44.01M | 115.65% |
Cash from investing | -21.87M | -136.83% |
Cash from financing | -38.14M | 28.04% |
Net change in cash | -15.71M | 62.79% |
Free cash flow | 38.69M | 46.10% |
About
Founded
Apr 2, 1997
Website
Employees
184
